Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

The World Health Organization (WHO) issued its first guidance on the use of Wegovy, Zepbound and other GLP-1 medications for ...

The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion ...

The next wave of obesity drugs is coming soon. Drug companies are racing to develop GLP-1 drugs following the blockbuster success of Novo Nordisk’s Ozempic and Wegovy and Eli Lilly’s Mounjaro and ...

Nanosized particles that release glucagon, the hormone responsible for raising blood glucose levels, on-demand could mean that diabetics don’t need to worry about potentially dangerous low blood sugar ...

CHICAGO & DUBLIN--(BUSINESS WIRE)-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ...

Scientists have provided new insight into the mechanisms by which blood levels of glucose — one of the main sources of energy for the cells in our body — are regulated. A team of researchers, led by ...

Study may be a step toward shelf-stable versions of the hormone, which is used to control diabetes. Patients with type 1 diabetes have to regularly inject themselves with insulin, a hormone that helps ...